60-Day FR

khammond on DSKJM1Z7X2PROD with NOTICES

Federal Register / Vol. 87, No. 173 / Thursday, September 8, 2022 / Notices
Instructions: All submissions must
include the Agency name and docket
number. For detailed instructions on
submitting comments, see the Public
Participation heading below. Note that
all comments received will be posted
without change to https://
www.regulations.gov, including any
personal information provided. Please
see the Privacy heading below.
Docket: For access to the docket to
read background documents or
comments received, go to https://
www.regulations.gov, and follow the
online instructions for accessing the
docket, or go to the street address listed
above.
Privacy: In accordance with 5 U.S.C.
553(c), DOT solicits comments from the
public to better inform its decision
making process. DOT posts these
comments, without edit, including any
personal information the commenter
provides, to www.regulations.gov, as
described in the system of records
notice (DOT/ALL–14 FDMS), which can
be reviewed at www.dot.gov/privacy.
Public Participation: The Federal
eRulemaking Portal is available 24
hours each day, 365 days each year. You
can obtain electronic submission and
retrieval help and guidelines under the
‘‘FAQ’’ section of the Federal
eRulemaking Portal website. If you want
us to notify you that we received your
comments, please include a selfaddressed, stamped envelope or
postcard, or print the acknowledgement
page that appears after submitting
comments online. Comments received
after the comment closing date will be
included in the docket and will be
considered to the extent practicable.
FOR FURTHER INFORMATION CONTACT: Ms.
Melissa Williams, Office of Safety,
Hazardous Materials Division, DOT,
FMCSA, West Building 6th Floor, 1200
New Jersey Avenue SE, Washington, DC
20590–0001; 202–366–4163;
melissa.williams@dot.gov.
SUPPLEMENTARY INFORMATION:
Background: The data for the
Transportation of Hazardous Materials;
Highway Routing ICR is collected under
authority of 49 U.S.C. 5112 and 5125.
Specifically, 49 U.S.C. 5112(c) requires
that the Secretary, in coordination with
the States, ‘‘shall update and publish
periodically a list of currently effective
hazardous material highway route
designations.’’ This authority is
delegated to FMCSA in 49 CFR
1.87(d)(2).
In 49 CFR 397.73, FMCSA requires
that each State and Indian tribe, through
its routing agency, provide information
identifying new, or changes to existing,
hazardous materials routing

VerDate Sep<11>2014

18:19 Sep 07, 2022

Jkt 256001

designations within its jurisdiction
within 60 days after their establishment
(or 60 days of the change). That
information is collected and
consolidated by FMCSA and published
annually, in whole or as updates, in the
Federal Register and on its website at
https://www.fmcsa.dot.gov/regulations/
hazardous-materials/nationalhazardous-materials-route-registry.
Title: Transportation of Hazardous
Materials, Highway Routing.
OMB Control Number: 2126–0014.
Type of Request: Renewal of a
currently approved ICR.
Respondents: The reporting burden is
shared by 50 States, the District of
Columbia, Indian tribes with designated
routes, and U.S. Territories including
Puerto Rico, American Samoa, Guam,
the Commonwealth of the Northern
Mariana Islands and the U.S. Virgin
Islands.
Estimated Number of Respondents: 57
[36 States + the District of Columbia,
with designated hazardous materials
highway routes + 19 States/U.S.
Territories without designated
hazardous materials highway routes + 1
Indian tribe with a designated route =
57].
Estimated Time per Response: 15
minutes.
Expiration Date: April 30, 2023.
Frequency of Response: Once every
two years.
Estimated Total Annual Burden: 7
hours [57 annual respondents × 1
response per 2 years × 15 minutes per
response/60 minutes per response =
7.125 hours rounded to 7 hours].
Public Comments Invited: You are
asked to comment on any aspect of this
information collection, including: (1)
whether the proposed collection is
necessary for the performance of
FMCSA’s functions; (2) the accuracy of
the estimated burden; (3) ways for
FMCSA to enhance the quality,
usefulness, and clarity of the collected
information; and (4) ways that the
burden could be minimized without
reducing the quality of the collected
information. The Agency will
summarize or include your comments in
the request for OMB’s clearance of this
ICR.
Issued under the authority of 49 CFR 1.87.
Thomas P. Keane,
Associate Administrator Office of Research
and Registration.
[FR Doc. 2022–19434 Filed 9–7–22; 8:45 am]
BILLING CODE 4910–EX–P

PO 00000

Frm 00124

Fmt 4703

Sfmt 4703

55077

DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2022–0133]

Agency Information Collection
Activities; Renewal of an Approved
Information Collection: 391.41 CMV
Driver Medication Form
Federal Motor Carrier Safety
Administration (FMCSA), Department
of Transportation (DOT).
ACTION: Notice and request for
comments.
AGENCY:

In accordance with the
Paperwork Reduction Act of 1995,
FMCSA announces its plan to submit
the renewal Information Collection
Request (ICR) described below to the
Office of Management and Budget
(OMB) for review and approval and
invites public comment. FMCSA
requests approval to renew an ICR
titled, ‘‘391.41 CMV Driver Medication
Form.’’ This Information Collection (IC)
is voluntary and may be utilized by
Medical Examiners (MEs) responsible
for issuing Medical Examiner’s
Certificates (MECs) to commercial motor
vehicle (CMV) drivers. MEs that choose
to use this IC do so to communicate
with treating healthcare professionals
who are responsible for prescribing
certain medications, so that the ME fully
understands the reasons the
medications have been prescribed. The
information obtained by the ME when
utilizing this IC assists the ME in
determining if the driver is medically
qualified and ensures that there are no
disqualifying medical conditions or
underlying medical conditions and
prescribed medications that could
adversely affect their safe driving ability
or cause incapacitation constituting a
risk to the public.
DATES: Comments on this notice must be
received on or before November 7, 2022.
ADDRESSES: You may submit comments
identified by Federal Docket
Management System Docket Number
FMCSA–2022–0133 using any of the
following methods:
• Federal eRulemaking Portal: http://
www.regulations.gov. Follow the online
instructions for submitting comments.
• Fax: (202) 493–2251.
• Mail: Dockets Operations; U.S.
Department of Transportation, 1200
New Jersey Avenue SE, West Building,
Ground Floor, Room W12–140,
Washington, DC 20590–0001.
• Hand Delivery or Courier: U.S.
Department of Transportation, 1200
New Jersey Avenue SE, West Building,
SUMMARY:

E:\FR\FM\08SEN1.SGM

08SEN1

khammond on DSKJM1Z7X2PROD with NOTICES

55078

Federal Register / Vol. 87, No. 173 / Thursday, September 8, 2022 / Notices

Ground Floor, Room W12–140,
Washington, DC 20590–0001 between 9
a.m. and 5 p.m. ET, Monday through
Friday, except Federal holidays.
Instructions: All submissions must
include the Agency name and docket
number. For detailed instructions on
submitting comments, see the Public
Participation heading below. Note that
all comments received will be posted
without change to https://
www.regulations.gov, including any
personal information provided. Please
see the Privacy Act heading below.
Docket: For access to the docket to
read background documents or
comments received, go to https://
www.regulations.gov, and follow the
online instructions for accessing the
docket, or go to the street address listed
above.
Privacy: In accordance with 5 U.S.C.
553(c), DOT solicits comments from the
public to better inform its PRA decisionmaking process. DOT posts these
comments, without edit, including any
personal information the commenter
provides, to www.regulations.gov, as
described in the system of records
notice (DOT/ALL–14 FDMS), which can
be reviewed at www.dot.gov/privacy.
Public Participation: The Federal
eRulemaking Portal is available 24
hours each day, 365 days each year. You
can obtain electronic submission and
retrieval help and guidelines under the
‘‘FAQ’’ section of the Federal
eRulemaking Portal website. If you want
us to notify you that we received your
comments, please include a selfaddressed, stamped envelope or
postcard, or print the acknowledgement
page that appears after submitting
comments online. Comments received
after the comment closing date will be
included in the docket and will be
considered to the extent practicable.
FOR FURTHER INFORMATION CONTACT: Ms.
Christine A. Hydock, Medical Programs
Division, DOT, FMCSA, West Building
6th Floor, 1200 New Jersey Avenue SE,
Washington, DC 20590–0001; (202) 366–
0421; christine.hydock@dot.gov.
SUPPLEMENTARY INFORMATION:
Background: FMCSA’s primary
mission is to reduce crashes, injuries,
and fatalities involving large trucks and
buses. The Secretary of Transportation
has delegated to FMCSA its
responsibility under 49 U.S.C. 31136
and 31502 to prescribe regulations that
ensure CMVs are operated safely. As
part of this mission, the Agency’s
Medical Programs Division works to
ensure that CMV drivers engaged in

VerDate Sep<11>2014

18:19 Sep 07, 2022

Jkt 256001

interstate commerce are physically
qualified and able to safely perform
their work.
The public interest in, and right to
have, safe highways requires the
assurance that drivers of CMVs can
safely perform the increased physical
and mental demands of their duties.
FMCSA’s physical qualification
standards provide this assurance by
requiring drivers to be examined and
medically certified as physically and
mentally qualified to drive.
The purpose for this voluntary IC is
to assist the ME in determining if the
driver is medically qualified under
§ 391.41 and to ensure that there are no
disqualifying medical conditions that
could adversely affect their safe driving
ability or cause incapacitation
constituting a risk to the public. Under
49 CFR 391.41(b)(12), a person is
physically qualified to drive a CMV if
that person does not use any drug or
substance identified in 21 CFR 1308.11
Schedule I, an amphetamine, a narcotic,
or other habit-forming drug; and does
not use any non-Schedule I drug or
substance that is identified in the other
Schedules in 21 CFR part 1308 except
when the use is prescribed by a licensed
medical practitioner, as defined in
§ 382.107, who is familiar with the
driver’s medical history and has advised
the driver that the substance will not
adversely affect the driver’s ability to
safely operate a CMV.
The use of this IC is at the discretion
of the ME and facilitates communication
with treating healthcare professionals
who are responsible for prescribing
certain medications so that the ME fully
understands the reasons the
medications have been prescribed. This
information assists the ME in
determining whether the underlying
medical condition and the prescribed
medication will impact the driver’s safe
operation of a CMV. Therefore, there is
no required collection frequency.
The ‘‘391.41 CMV Driver Medication
Form, MCSA–5895,’’ may be
downloaded from the FMCSA website.
Prescribing healthcare providers are also
able to fax or scan and email the report
to the certified ME. Consistent with
OMB’s commitment to minimizing
respondents’ recordkeeping and
paperwork burdens and the increased
use of secure electronic modes of
communication, the Agency believes
that approximately 50 percent of the
‘‘391.41 CMV Driver Medication Forms,
MCSA–5895,’’ are transmitted
electronically.

PO 00000

Frm 00125

Fmt 4703

Sfmt 4703

The information collected from the
‘‘391.41 CMV Driver Medication Form,
MCSA–5895,’’ is used by the certified
ME that requested the completion of the
form. The ‘‘391.41 CMV Driver
Medication Form, MCSA–5895,’’ is
attached to the ‘‘Medical Examination
Report Form, MCSA–5875,’’ which
becomes part of the CMV driver’s record
maintained by the certified ME. The
information is not available to the
public. The Federal Motor Carrier Safety
Regulations covering driver physical
qualification records are found at
§ 391.43, which specify that a medical
examination be performed on CMV
drivers subject to part 391 who operate
in interstate commerce. The results of
the examination must be recorded in
accordance with the requirements set
forth in that section. MEs are required
to maintain records of the CMV driver
medical examinations they conduct.
Title: 391.41 CMV Driver Medication
Form.
OMB Control Number: 2126–0064.
Type of Request: Renewal of a
currently approved collection.
Respondents: Prescribing healthcare
professionals.
Estimated Number of Respondents:
Up to 1,163,160 (total number of
prescribing healthcare providers in the
U.S.).
Estimated Time per Response: 8
minutes.
Expiration Date: April 30, 2023.
Frequency of Response: Other (use of
this IC is optional so there is no
required collection frequency).
Estimated Total Annual Burden:
279,465 hours.
Public Comments Invited: You are
asked to comment on any aspect of this
IC, including: (1) whether the proposed
collection is necessary for the
performance of FMCSA’s functions; (2)
the accuracy of the estimated burden;
(3) ways for FMCSA to enhance the
quality, usefulness, and clarity of the
collected information; and (4) ways that
the burden could be minimized without
reducing the quality of the collected
information. The Agency will
summarize or include your comments in
the request for OMB’s clearance of this
ICR.
Issued under the authority of 49 CFR 1.87.
Thomas P. Keane,
Associate Administrator, Office of Research
and Registration.
[FR Doc. 2022–19438 Filed 9–7–22; 8:45 am]
BILLING CODE 4910–EX–P

E:\FR\FM\08SEN1.SGM

08SEN1